Who invested in TearScience?
TearScience's investors include HealthCare Royalty Partners, General Catalyst, Investor AB, De Novo Ventures and Essex Woodlands Healthcare Partners, and 2 more on record.
United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$185Mraised across 3 rounds since 2010, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by onbiovc.comSEC filing: $40M sold, first sale May 2010
From the SEC filings it signed: 2 on the team.
On the board, as filediAbhijeet LeleImmanuel ThangarajJoe MandatoJoel CutlerTodd Davis
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
TearScience's investors include HealthCare Royalty Partners, General Catalyst, Investor AB, De Novo Ventures and Essex Woodlands Healthcare Partners, and 2 more on record.
TearScience has raised $185M across 3 rounds since 2010.
TearScience's most recent round was a Series D of $70M in Feb 2013.
TearScience's largest round on record is $70M (Growth), in Feb 2013.
TearScience's first round on record, in May 2010, was backed by General Catalyst, Investor AB and De Novo Ventures and 3 others.
TearScience's latest named round is a Series D, in Feb 2013.
TearScience is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.